ALERT: This system is being upgraded on Tuesday December 12. It will not be available for use for several hours that day while the upgrade is in progress. Deposits to DukeSpace will be disabled on Monday December 11, so no new items are to be added to the repository while the upgrade is in progress. Everything should be back to normal by the end of day, December 12.

Browsing by Author "He, Wensheng"

Now showing items 1-4 of 4

    • Effect of cord blood processing on transplantation outcomes after single myeloablative umbilical cord blood transplantation. 

      Ballen, Karen K; Logan, Brent R; Laughlin, Mary J; He, Wensheng; Ambruso, Daniel R; Armitage, Susan E; Beddard, Rachel L; ... (29 authors) (Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2015-04)
      Variations in cord blood manufacturing and administration are common, and the optimal practice is not known. We compared processing and banking practices at 16 public cord blood banks (CBB) in the United States and assessed ...

    • Outcome of transplantation for acute lymphoblastic leukemia in children with Down syndrome. 

      Hitzler, Johann K; He, Wensheng; Doyle, John; Cairo, Mitchell; Camitta, Bruce M; Chan, Ka Wah; Diaz Perez, Miguel A; ... (21 authors) (Pediatric blood & cancer, 2014-06)
      We report on 27 patients with Down syndrome (DS) and acute lymphoblastic leukemia (ALL) who received allogeneic hematopoietic cell transplantation (HCT) between 2000 and 2009. Seventy-eight percent of patients received ...

    • Outcome of transplantation for acute myelogenous leukemia in children with Down syndrome. 

      Hitzler, Johann K; He, Wensheng; Doyle, John; Cairo, Mitchell; Camitta, Bruce M; Chan, Ka Wah; Diaz Perez, Miguel A; ... (21 authors) (Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2013-06)
      Data on outcomes of allogeneic transplantation in children with Down syndrome and acute myelogenous leukemia (DS-AML) are scarce and conflicting. Early reports stress treatment-related mortality as the main barrier; a recent ...

    • Outcomes after hematopoietic stem cell transplantation for children with I-cell disease. 

      Lund, Troy C; Cathey, Sara S; Miller, Weston P; Eapen, Mary; Andreansky, Martin; Dvorak, Christopher C; Davis, Jeffrey H; ... (19 authors) (Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2014-11)
      Mucolipidosis type II (MLII), or I-cell disease, is a rare but severe disorder affecting localization of enzymes to the lysosome, generally resulting in death before the 10th birthday. Although hematopoietic stem ...